ADC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Archives of Disease in Childhood 2006;91:929-935; doi:10.1136/adc.2005.086306
Copyright © 2006 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in ADC Online
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bonhoeffer, J
Right arrow Articles by Heath, P T
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bonhoeffer, J
Right arrow Articles by Heath, P T
Topic Collections
Right arrowRelevant Article

REVIEW

Immunisation of premature infants

J Bonhoeffer1, C-A Siegrist2, P T Heath1

1 St George’s Hospital, London, UK
2 University of Geneva, Geneva, Switzerland

Correspondence to:
Correspondence to:
Dr Paul T Heath
Division of Child Health, St George’s, University of London Cranmer Terrace, London SW17 0RE, UK; pheath{at}sgul.ac.uk


ABSTRACT
Premature infants are at increased risk of vaccine preventable infections, but audits have shown that their vaccinations are often delayed. Early protection is desirable. While the evidence base for immunisation of preterm infants is limited, the available data support early immunisation without correction for gestational age. For a number of antigens the antibody response to initial doses may be lower than that of term infants, but protective concentrations are often achieved and memory successfully induced. A 2-3-4 month schedule may be preferable for immunisation of preterm infants in order to achieve protection as early as possible, but an additional dose may be required to achieve persistence of protection. This update focuses on the use of routine childhood vaccines in premature infants.


Abbreviations: AEFI, adverse events following immunisation; DTaP, diphtheria-tetanus-acellular pertussis vaccine; DTwP, diphteria-tetanus-whole cell pertussis vaccine; GMC, geometric mean concentration; GMT, geometric mean titre; Hep B, hepatitis B; Hib, Haemophilus influenzae type b; IPV, inactivated polio vaccine; MenC, meningococcal group C conjugate; MMR, measles-mumps-rubella; PCV, pneumococcal conjugate vaccine; PPD, purified protein derivative

Keywords: immunisation; prematurity; review; vaccine


Relevant Article

A brief digest of the November issue
Arch. Dis. Child. 2006 91: e7. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
J. Virol.Home page
J. S. Tregoning, Y. Yamaguchi, J. Harker, B. Wang, and P. J. M. Openshaw
The Role of T Cells in the Enhancement of Respiratory Syncytial Virus Infection Severity during Adult Reinfection of Neonatally Sensitized Mice
J. Virol., April 15, 2008; 82(8): 4115 - 4124.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
ARCH DIS CHILD FETAL NEONATAL ED ED PRACTICE
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health